Additional value of integrated <sup>18</sup>F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile.

Details

Serval ID
serval:BIB_36FE4130B5A5
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Additional value of integrated <sup>18</sup>F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile.
Journal
European journal of nuclear medicine and molecular imaging
Author(s)
Piccardo A., Trimboli P., Rutigliani M., Puntoni M., Foppiani L., Bacigalupo L., Crescenzi A., Bottoni G., Treglia G., Paparo F., Del Monte P., Lanata M., Paone G., Ferrarazzo G., Catrambone U., Arlandini A., Ceriani L., Cabria M., Giovanella L.
ISSN
1619-7089 (Electronic)
ISSN-L
1619-7070
Publication state
Published
Issued date
03/2019
Peer-reviewed
Oui
Volume
46
Number
3
Pages
766-775
Language
english
Notes
Publication types: Clinical Trial ; Journal Article
Publication Status: ppublish
Abstract
The localization of hyperfunctioning parathyroid gland(s) (HPTG) in patients with primary hyperparathyroidism (PHPT) with negative or inconclusive first-line imaging is a significant challenge. This study aimed to evaluate the role of integrated <sup>18</sup> F-choline PET/4D contrast-enhanced computed tomography (4DCeCT) in these patients, compare its detection rate and sensitivity with those of <sup>18</sup> F-choline PET/CT and (4DCeCT), and analyse the association between choline metabolism and morphological, biochemical and molecular parameters of HPTG.
We prospectively enrolled 44 PHPT patients with negative or inconclusive first-line imaging. <sup>18</sup> F-Choline PET/CT and 4DCeCT were performed at the same time, and integrated <sup>18</sup> F-choline PET/4DCeCT images were obtained after coregistration. Experienced physicians examined the images. The SUVratio and degree of contrast enhancement were recorded for each positive finding. Histopathology, laboratory and multidisciplinary follow-up were used as the standard of reference. Both the detection rates and sensitivities of the three imaging modalities were calculated retrospectively. Immunohistochemistry was performed to evaluate the molecular profile of HPTGs.
<sup>18</sup> F-Choline PET/4DCeCT was positive in 32 of 44 patients with PHPT (detection rate 72.7%), and 31 of 31 surgically treated patients (sensitivity 100%). These results were significantly (p < 0.05) better than those of <sup>18</sup> F-choline PET/CT (56.8% and 80%, respectively) and those of 4DCeCT (54.5 and 74%, respectively). A significant correlation between SUV and calcium level was found. In a multivariate analysis, only calcium level was significantly associated with <sup>18</sup> F-choline PET/4DCeCT findings. SUVratio and Ki67 expression were significantly correlated.
Integrated <sup>18</sup> F-choline PET/4DCeCT should be considered as an effective tool to detect PHPT in patients with negative or inconclusive first-line imaging. Choline metabolism is correlated with both calcium level and Ki67 expression in HPTG.
Keywords
Aged, Aged, 80 and over, Choline/analogs & derivatives, Contrast Media, Female, Four-Dimensional Computed Tomography, Humans, Hyperparathyroidism, Primary/diagnostic imaging, Hyperparathyroidism, Primary/physiopathology, Image Interpretation, Computer-Assisted, Male, Middle Aged, Parathyroid Glands/diagnostic imaging, Parathyroid Glands/physiopathology, Positron Emission Tomography Computed Tomography, 18F-Choline, 4DCeCT, Elderly, Hyperparathyroidism, Molecular profile
Pubmed
Web of science
Create date
30/06/2019 17:00
Last modification date
21/08/2019 5:34
Usage data